Your browser doesn't support javascript.
loading
Phase 1 study of safety, tolerability and immunogenicity of the human telomerase (hTERT)-encoded DNA plasmids INO-1400 and INO-1401 with or without IL-12 DNA plasmid INO-9012 in adult patients with solid tumors.
Vonderheide, Robert H; Kraynyak, Kimberly A; Shields, Anthony F; McRee, Autumn J; Johnson, Jennifer M; Sun, Weijing; Chintakuntlawar, Ashish V; Pawlicki, Jan; Sylvester, Albert J; McMullan, Trevor; Samuels, Robert; Kim, Joseph J; Weiner, David; Boyer, Jean D; Morrow, Matthew P; Humeau, Laurent; Skolnik, Jeffrey M.
Afiliación
  • Vonderheide RH; Abramson Cancer Center, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA.
  • Kraynyak KA; Inovio Pharmaceuticals, Plymouth Meeting, Pennsylvania, USA kim.kraynyak@inovio.com.
  • Shields AF; Karmanos Cancer Institute, Wayne State University, Detroit, Michigan, USA.
  • McRee AJ; University of North Carolina Lineberger Comprehensive Cancer Center, Chapel Hill, North Carolina, USA.
  • Johnson JM; Sidney Kimmel Cancer Center, Thomas Jefferson University, Philadelphia, Pennsylvania, USA.
  • Sun W; University of Kansas Medical Center, Department of Medicine, Division of Medical Oncology, Kansas City, Kansas, USA.
  • Chintakuntlawar AV; Division of Medical Oncology, Mayo Clinic, Rochester, Minnesota, USA.
  • Pawlicki J; Inovio Pharmaceuticals, Plymouth Meeting, Pennsylvania, USA.
  • Sylvester AJ; Inovio Pharmaceuticals, Plymouth Meeting, Pennsylvania, USA.
  • McMullan T; Inovio Pharmaceuticals, Plymouth Meeting, Pennsylvania, USA.
  • Samuels R; Inovio Pharmaceuticals, Plymouth Meeting, Pennsylvania, USA.
  • Kim JJ; Inovio Pharmaceuticals, Plymouth Meeting, Pennsylvania, USA.
  • Weiner D; Wistar Institute, Philadelphia, Pennsylvania, USA.
  • Boyer JD; Inovio Pharmaceuticals, Plymouth Meeting, Pennsylvania, USA.
  • Morrow MP; Inovio Pharmaceuticals, Plymouth Meeting, Pennsylvania, USA.
  • Humeau L; Inovio Pharmaceuticals, Plymouth Meeting, Pennsylvania, USA.
  • Skolnik JM; Inovio Pharmaceuticals, Plymouth Meeting, Pennsylvania, USA.
J Immunother Cancer ; 9(7)2021 07.
Article en En | MEDLINE | ID: mdl-34230114
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Plásmidos / ADN / Interleucina-12 / Telomerasa / Inmunoterapia / Neoplasias Tipo de estudio: Clinical_trials Límite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Revista: J Immunother Cancer Año: 2021 Tipo del documento: Article País de afiliación: Estados Unidos
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Plásmidos / ADN / Interleucina-12 / Telomerasa / Inmunoterapia / Neoplasias Tipo de estudio: Clinical_trials Límite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Revista: J Immunother Cancer Año: 2021 Tipo del documento: Article País de afiliación: Estados Unidos